<DOC>
	<DOCNO>NCT02934685</DOCNO>
	<brief_summary>To determine hypofractionated IG-VMAT ( 70 Gy 28 fraction 5.6 week ) result disease-free survival ( DFS ) bad DFS follow conventionally fractionate IG-VMAT ( 80Gy 40 fraction 8 week ) patient treat localized prostate cancer . Analysis local progression , disease-specific survival ( DFS ) , freedom biochemical recurrence ( FFBR ) , overall survival ( OS ) two group . Observe incidence GI GU toxicity .</brief_summary>
	<brief_title>IG-VMAT Localized Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Age 5079 Histologically confirm prostate adenocarcinoma Clinical stage T13N0M0 accord AJCC 6th edition Gleason score must &gt; 5 KPS &gt; 70 No radical surgery cryosurgery prostate cancer Prior concurrent invasive malignancy ( except nonmelanomatous skin cancer ) lymphomatous/hematogenous malignancy unless continually disease free minimum 5 year . ( For example , carcinoma situ bladder oral cavity permissible ) Evidence distant metastasis Previous radical surgery ( prostatectomy ) cryosurgery prostate cancer Previous pelvic irradiation , prostate brachytherapy , bilateral orchiectomy Previous concurrent cytotoxic chemotherapy prostate cancer</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Prostatic Neoplasms</keyword>
	<keyword>radiotherapy</keyword>
</DOC>